374 related articles for article (PubMed ID: 37528041)
1. [Erythrocytosis after hematopoietic stem cell transplantation: report of 3 cases and literature review].
Qin LL; Mo XD; Han TT; Han W; Huang XJ; Xu LP
Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):1012-1016. PubMed ID: 37528041
[TBL] [Abstract][Full Text] [Related]
2. A rare complication after allogeneic stem cell transplantation: post-transplant erythrocytosis.
Atilla E; Topcuoglu P; Ataca P; Pekcan G; Bozdag SC; Yuksel MK; Ozcan M; Gurman G; Toprak SK
Clin Transplant; 2016 Jun; 30(6):669-72. PubMed ID: 27028115
[TBL] [Abstract][Full Text] [Related]
3. [Erythrocytosis following allogeneic hematopoietic stem cell transplantation].
Kawahara H; Takakuwa T; Nakamae M; Kubota H; Okamura H; Nanno S; Nakashima Y; Nakane T; Koh H; Hirose A; Hino M; Nakamae H
Rinsho Ketsueki; 2020; 61(10):1492-1496. PubMed ID: 33162446
[TBL] [Abstract][Full Text] [Related]
4. Erythrocytosis following allogeneic hemopoietic SCT in three cases of aplastic anemia.
Ahmed P; Chaudhry QU; Satti TM; Raza S; Mahmood SK
Bone Marrow Transplant; 2011 Aug; 46(8):1163-5. PubMed ID: 21057557
[No Abstract] [Full Text] [Related]
5. Erythrocytosis after allogeneic hematopoietic stem cell transplantation.
Hino Y; Doki N; Kurosawa S; Yamamoto K; Sakaguchi M; Harada K; Ikegawa S; Shingai N; Hattori K; Senoo Y; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28247439
[No Abstract] [Full Text] [Related]
6. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
Rzepecki P; Sarosiek T; Szczylik C
Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
[TBL] [Abstract][Full Text] [Related]
7. Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Dufour C; Pillon M; Passweg J; Socié G; Bacigalupo A; Franceschetto G; Carraro E; Oneto R; Risitano AM; Peffault de Latour R; Tichelli A; Rovo A; Peters C; Hoechsmann B; Samarasinghe S; Kulasekararaj AG; Schrezenmeier H; Aljurf M; Marsh J
Haematologica; 2014 Oct; 99(10):1574-81. PubMed ID: 25085353
[TBL] [Abstract][Full Text] [Related]
8. Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Hussein AA; Halkes CM; Socié G; Tichelli A; von dem Borne PA; Schaap MN; Foa R; Ganser A; Dufour C; Bacigalupo A; Locasciulli A; Aljurf M; Peters C; Robin M; van Biezen AA; Volin L; De Witte T; Marsh J; Passweg JR; Kröger N;
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1448-50. PubMed ID: 24910382
[TBL] [Abstract][Full Text] [Related]
9. Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation.
Takenaka K; Onishi Y; Mori T; Hirakawa T; Tada Y; Uchida N; Kobayashi T; Kanda Y; Ozawa Y; Ota S; Iida H; Fukushima K; Kimua T; Fukuda T; Atsuta Y; Matsuto K; Yamazaki H; Nakasone H
Transplant Cell Ther; 2021 Jan; 27(1):82.e1-82.e8. PubMed ID: 33039517
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation.
Kim SY; Le Rademacher J; Antin JH; Anderlini P; Ayas M; Battiwalla M; Carreras J; Kurtzberg J; Nakamura R; Eapen M; Deeg HJ
Haematologica; 2014 Dec; 99(12):1868-75. PubMed ID: 25107891
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
[TBL] [Abstract][Full Text] [Related]
12. Pre-Transplant Platelet Refractoriness and Alternative Donors Are Associated With Cytomegalovirus Retinitis in Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia.
Zhang Y; Liang Y; Zhang X; Wang S; Cao J; Gao Z; Li L; Mo W
Front Cell Infect Microbiol; 2022; 12():870296. PubMed ID: 35372094
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience.
Wang H; Wang Z; Zheng X; Ding L; Zhu L; Yan H; Guo Z
Cytotherapy; 2013 Sep; 15(9):1118-25. PubMed ID: 23806238
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC;
Haematologica; 2012 Aug; 97(8):1142-8. PubMed ID: 22315497
[TBL] [Abstract][Full Text] [Related]
15. Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia.
Ma X; Zuo Y; Xu Z; Zhang Y; Cheng Y; Han T; Suo P; Sun Y; Tang F; Wang F; Yan C; Chen Y; Wang Y; Zhang X; Liu K; Huang X; Xu L
Ann Hematol; 2022 Aug; 101(8):1815-1823. PubMed ID: 35739427
[TBL] [Abstract][Full Text] [Related]
16. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
17. Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases.
Song X; Qi J; Li X; Zhou M; He J; Chu T; Han Y
Platelets; 2023 Dec; 34(1):2229905. PubMed ID: 37409458
[TBL] [Abstract][Full Text] [Related]
18. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia.
Mori T; Onishi Y; Ozawa Y; Kato C; Kai T; Kanda Y; Kurokawa M; Tanaka M; Ashida T; Sawayama Y; Fukuda T; Ichinohe T; Atsuta Y; Yamazaki H
Int J Hematol; 2019 Jun; 109(6):711-717. PubMed ID: 30963471
[TBL] [Abstract][Full Text] [Related]
19. Cotransplantation of haploidentical hematopoietic stem cells and allogeneic bone marrow-derived mesenchymal stromal cells as a first-line treatment in very severe aplastic anemia patients with refractory infections.
Yue C; Ding Y; Gao Y; Li L; Pang Y; Liu Z; Zhang H; Xiao Y; Jiang Z; Xiao H
Eur J Haematol; 2018 Jun; 100(6):624-629. PubMed ID: 29532539
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions.
Sun Q; Wu B; Zhu Z; Sun C; Xu J; Long H; Huang Y; Xu J; Song C
Curr Stem Cell Res Ther; 2018; 13(5):350-355. PubMed ID: 28245775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
